The global Lactoferrin market size is expected to be worth around US$ 511.8 million by 2030, according to a new report by Vision Research Reports.
The global Lactoferrin market size was valued at US$ 260.2 million in 2020 and is anticipated to grow at a CAGR of 12.2% during forecast period 2021 to 2030.
Get Sample Copy of This Report (Including TOC, List of Tables & Figures, and Chart)@ https://www.visionresearchreports.com/report/sample/38450
Lactoferrin Market (By Function, Iron Absorption, Anti-inflammatory, Intestinal Flora Protection, Antibacterial, Immune Cell Stimulation, Antioxidant; By Application: Food & Beverages, Infant Formula, Sports & Functional Foods, Pharmaceuticals, Personal Care Products, Animal Feed) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030
Growth Factors
Increasing incorporation of lactoferrin in various products ranges including infant food, food supplements, dietetic foods, alcoholic beverages, sports nutrition, and personal care and cosmetics should bolster lactoferrin market in the forecast timeframe, ascribed to strong health benefits.
Lactoferrin offers stimulating effects on immune system, prevents cell damage caused by aging, promotes culture of beneficial bacterial in the intestinal tract, and regulates viruses, bacteria and fungi along with being regulator to iron metabolism. Lactoferrin is found effective for the treatment of hepatitis C infection by inhibiting replication of the virus at intracellular level. Hence, strong applicability of lactoferrin in nutraceutical, pharmaceutical, and personal care industries is anticipated to drive demand during the forecast period.
Report Highlights
The iron absorption segment accounted for the highest revenue share of more than 39% in 2020 and is expected to maintain its leading position over the forecast period. Iron deficiency usually leads to anemia, which roughly affects over 40% of the global population. Lactoferrin has been a crucial solution for anemia, its high level of bioavailability along with the ability to increase serum ferritin levels by five times allows efficient absorption of iron when compared to other iron sources.
The infant formula segment held the highest revenue share of more than 48% in 2020 and will expand further at a steady CAGR from 2021 to 2030. The demand is anticipated to grow owing to the increase in the number of clinical studies supporting infant formula integration with lactoferrin and changing consumer dynamics towards infant supplementary foods. The demand for infant nutrition is majorly from the developed economies owing to the significant disposable income, busy work schedules, and rising incidences of iron deficiency among infants.
Asia Pacific emerged as the largest regional market in 2020 with a revenue share of more than 52%. The regional market is expected to maintain its position throughout the forecast period. Led by India, China, and Japan, the regional market growth can be attributed to the growing population and rising spending capacity of the consumers. Asia Pacific, unlike most other regions, has a sizable number of medium and small businesses. Moreover, with increasing literacy rate and rising consumer awareness regarding infant nutrition, personal care, and pharmaceutical products along with consumer inclination toward organic products are expected to drive the market growth.
Key Players
- Hilmar Cheese Company
- Pharming Group NV
- FrieslandCampina
- Synlait Milk Ltd.
- Ingredia SA
- MP Biomedicals
- Tatura Milk Industries Ltd.
- Glanbia plc
- APS BioGroup
- ProHealth
- Fonterra Cooperative Group Ltd.
- Farbest Brands
- InVitria
- Milei GmbH
- Ferrin-tech LLC
| Report Coverage | Details |
| Market Size | US$ 511.8 million by 2030 |
| Growth Rate | CAGR of 12.2% From 2021 to 2030 |
| Base Year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Function, Application |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Hilmar Cheese Company; Pharming Group NV; FrieslandCampina; Synlait Milk Ltd.; Ingredia SA; MP Biomedicals; Tatura Milk Industries Ltd.; Glanbia plc; APS BioGroup; ProHealth; Fonterra Cooperative Group Ltd.; Farbest Brands; InVitria; Milei GmbH; Ferrin-tech LLC |
Market Segmentation
- Function
- Iron Absorption
- Anti-inflammatory
- Intestinal Flora Protection
- Antibacterial
- Immune Cell Stimulation
- Antioxidant
- Application
- Food & Beverages
- Infant Formula
- Sports & Functional Foods
- Pharmaceuticals
- Personal Care Products
- Animal Feed
- Regional
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Asia Pacific
- China
- India
- Japan
- Australia
- Central & South America
- Brazil
- Middle East & Africa
- UAE
- North America
The study objectives of this report are:
- To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
- Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- To define, describe and forecast the market by type, application and region.
- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
- To identify significant trends and factors driving or inhibiting the market growth.
- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
- To strategically profile the key players and comprehensively analyze their growth strategies.
Buy This Premium Research Report, click here@ https://www.visionresearchreports.com/report/cart/38450 or call: +1 9197 992 333